Efficacy and Safety of Esketamine Combined with Antidepressants for Treatment-Resistant Depression: A Meta-Analysis
Peng Liu,1,2 Shan-Shan Zhang,1,2 Yun Liang,1,2 Zi-Jun Gao,1 Wei Gao,3 Bu-Huai Dong1 1Department of Anesthesiology, Xi’an Honghui Hospital, Affiliated Hospital of Xi’an Jiaotong University, Xi’an, People’s Republic of China; 2Xi’an Medical University, Xi’an, People’s Republic of China; 3Department of...
Main Authors: | Liu P, Zhang SS, Liang Y, Gao ZJ, Gao W, Dong BH |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-12-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-safety-of-esketamine-combined-with-antidepressants-for-tr-peer-reviewed-fulltext-article-NDT |
Similar Items
-
Early real-life evaluation of the efficacy of esketamine in resistant depressive disorder
by: S. Faisant, et al.
Published: (2022-06-01) -
Clinical efficacy and tolerability of Esketamine: a case series
by: C. Passani, et al.
Published: (2022-06-01) -
Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis
by: Alessandro Rodolico, et al.
Published: (2024-02-01) -
Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality
by: Dong-Jing Fu, et al.
Published: (2023-08-01) -
Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression
by: D. Hernandez Huerta, et al.
Published: (2022-06-01)